Accreditations & Approvals Featured Venus Pharma GmbH Receives Marketing Authorization for Cisplatin from UK MHRA Venus Pharma GmbH, the German subsidiary of Venus Remedies Limited, has recently received a Marketing Authorization (MA) certificate from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its chemotherapy drug, Cisplatin. The company has been granted the license to market this drug in three different strengths: 10mg-10ml, 50mg-50ml,
Accreditations & Approvals Featured Venus Remedies Limited Expands Presence in Asia with New Representative Office in Vietnam Venus Remedies Limited has been granted a representative office license in Vietnam, expanding our reach and allowing us to provide even more comprehensive healthcare solutions to patients in the region. Venus Remedies Limited is a leading pharmaceutical company committed to providing innovative and high-quality healthcare solutions to people worldwide. With
Accreditations & Approvals Featured Barbados Drug Service Approves Venus Remedies Limited Products for Use in the Country The Barbados Drug Service has approved Venus Remedies Limited products for use in the country, marking a significant step forward in our commitment to providing innovative and high-quality healthcare solutions worldwide. The Barbados Drug Service is a government agency responsible for regulating and providing access to essential drugs and healthcare
Accreditations & Approvals Featured Saudi Arabia helps lift Venus's International GMP Certifications to 20 Venus recently received Good Manufacturing Practices (GMP) Certification from Saudi Arabia for all its production facilities at its Baddi, Himachal Pradesh unit, thus taking the organization's total global GMP certifications to 20. The Saudi Food and Drug Authority (SFDA) while granting this certification also renewed the approval for Cephalosporin and
Accreditations & Approvals Featured Venus Receives Marketing Authorization for its Generic Cancer Drugs Venus has been working on target-based drug delivery for cancer treatment and diagnostics. The company has recently received marketing authorizations for its cancer drugs from Uzbekistan and Palestine. It has received marketing approval for Carboplatin in Uzbekistan and Docetaxel and Irinotecan in Palestine. With over 800 marketing authorizations worldwide, this
Accreditations & Approvals Featured Venus certified as a "Responsible Export Organization" by the CII Venus emerged as the first pharma company in the country to have received the prestigious Responsible Export Organisation (REO) Certification from the Confederation of Indian Industry (CII) following an elaborate screening and assessment process. The certification is an endorsement of the company’s export capabilities and manufacturing prowess. It will
Accreditations & Approvals Featured Venus awarded with "Good Distribution Practices" certification Venus received the coveted Good Distribution Practices (GDP) Certification (WHO TRS 957 ANNEX-5) for quality services throughout the Supply Chain Cycle, i.e., from product manufacturing to delivery to end-consumer. SGS (Société Générale de Surveillance) is the world’s leading testing, inspection and certification company. SGS awarded this remarkable certification